Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. And the group that holds ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Leerink Partners analyst Geoff Porges maintained a Hold rating on Pfizer on Friday, setting a price target of $39, which is... (Reuters) - Moderna (NASDAQ:MRNA) Inc has delayed the shipment of ...

We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...

(Reuters) - The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc (NYSE:PFE)'s next-generation vaccine to prevent ...

Pfizer's revenue has stabilized ... According to the seasonality bar chart above, April is historically a weak month for PFE. On the other hand, we have three historically strong months after ...

Next: Get access to a new market-moving chart every day featuring a stock ... In addition, write-downs by BioNTech’s collaboration partner Pfizer Inc PFE significantly reduced the company ...

Pfizer is one of the world's largest pharmaceutical ... 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Uncle Sam’s abiding ambivalence about having close ties with corporate America is getting some fresh, albeit unwelcome, ...

Sleep Aids Market Share 2025 Sleep Aids Market is estimated to be valued at USD 83.75 Bn in 2025 and is expected to reach USD 141.77 Bn by ...

Cancer Biologics Market 2025 Biologic drug is a product that contain components of living organisms such as animal, human, or produced from ...